- 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
FDA- QSR 820英文原版
[Code of Federal Regulations] [Title 21, Volume 8] [Revised as of April 1, 2015] [CITE: 21CFR820] TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H--MEDICAL DEVICES PART 820 QUALITY SYSTEM REGULATION Subpart A--General Provisions Sec. 820.1 Scope. (a) Applicability. (1) Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. The requirements in this part are intended to ensure that finished devices will be safe and effective and otherwise in compliance with the Federal Food, Drug, and Cosmetic Act (the act). This part establishes basic requirements applicable to manufacturers of finished medical devices. If a manufacturer engages in only some operations subject to the requirements in this part, and not in others, that manufacturer need only comply with those requirements applicable to the operations inwhich it is engaged. With respect to class I devices, design controls apply only to those devices listed in 820.30(a)(2). This regulation does not apply to manufacturers of components or parts of finished devices, but such manufacturers are encouraged to use appropriate provisions of this regulation as guidance. Manufacturers of human blood and blood components are not subject to this part, but are subject to part 606 of this chapter. Manufacturers of human cells, tissues, an
您可能关注的文档
- 纯化水欧洲药典8.0.pdf
- 欧洲药典各类溶液配制方法.pdf
- EP6.4欧洲越橘.pdf
- 氟维司群EP标准.pdf
- 草酸萘呋胺 EP 8.0.pdf
- 替米沙坦-EP.pdf
- 盐酸多塞平欧洲药典8.0EP02729.pdf
- 依诺肝素钠标准(EP 8.1).pdf
- 熊去氧胆酸原料标准Ursodeoxycholic Acid (EP9.0).pdf
- 欧洲药典 EP8.0Heparins, low-molecular-mass.pdf
- FDA 华法令指导原则Warfarin Sodium.pdf
- L_去氧肾上腺素合成研究进展_李国华.pdf
- Effects of food additives information on consumers’ risk perceptions and willingness to accept.pdf
- FDA工艺验证指南的特点分析_201608111242.pdf
- FDA:基于生物药剂学分类系统的口服固体速释制剂体内生物利用度和生物等效性研究的豁免.pdf
- 基于GC_MS的植物代谢组学研究.pdf
- 美国FDA-21CFR820法规(详细)英文版.pdf
- 2014FDA标准.pdf
- FDA 铅含量测试方法.pdf
- FDA QC实验室审计.pdf
文档评论(0)